Acknowledgments
The data acquisition from which this analysis was derived was funded by National Institute of Mental Health grants MH-41314, HD036317, and MH050657 to Dr. Joseph Biederman. The manuscript and the analysis of the data were indirectly supported by the Pediatric Psychopharmacology Research Council Fund and the Saylor family fund supporting research in autism. Dr. Gagan Joshi is supported by the National Institute of Mental Health of the National Institutes of Health under award no. K23MH100450. Professor Faraone is supported by the K.G. Jebsen Centre for Research for Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; the European Union’s Seventh Framework Programme for Research, Technological Development, and Demonstration under grant agreement no. 602805, and National Institute of Mental Health grant nos. R13MH059126 and R01MH094469.